[Clinico-physiological rationale for the use of the mesodiencephalic modulation in combination with synobiotics in the irritable bowel syndrome].
M T
MT
Efendieva
E V
EV
Gusakova
D000293:Adolescent; D000328:Adult; D001644:Bifidobacterium; D003131:Combined Modality Therapy; D004599:Electric Stimulation Therapy; D005260:Female; D006801:Humans; D007422:Intestines / Q000382:microbiology / Q000503:physiopathology*; D043183:Irritable Bowel Syndrome / Q000382:microbiology / Q000628:therapy*; D007779:Lactobacillus acidophilus; D008297:Male; D008875:Middle Aged